Report highlights growing confidence in digitalisation and AI, even as healthcare leaders remain concerned about workforce gaps, cybersecurity, and data readiness
Approval expands Lupin’s specialty portfolio in the US market for treatment of urea cycle disorders
Under the new policy, financial assistance has been increased to Rs 50 lakh per patient to improve treatment access
Company plans to appeal against CGST order related to alleged inadmissible input tax credit claims
Pharma and healthcare stocks stay in focus as investors track earnings, USFDA approvals, hospital growth, and global market pressures
Keeps Halo Pharma to drive independent growth
Dr Mohit Bhandari remotely conducted a complex robotic gastrojejunostomy from Perth using the indigenous SSI Mantra Surgical Robotic System
The company secured new accounts, including ACCESS-PVI trial sites, and aims to strengthen global commercialization efforts
The company says the product will now be distributed exclusively through Anovo Specialty Pharmacy
Subscribe To Our Newsletter & Stay Updated
